Signe Fransen

Signe is an experienced global scientific & medical affairs leader and scientist with a passion for oncology, and virology and the goal of bringing new therapies and diagnostics to market.

Signe started her career in Canada working at the British Columbia Center for Excellence in HIV/AIDS before completing her graduate studies in Immunology and transitioning to the U.S. to gain experience with both small and large biotechnology companies.

Signe has over 25 years of biotech and pharma experience, specializing in personalized medicine both relating to HIV-1 drug resistance and oncology. She has a strong background in virology, molecular biology and immunology.

Signe spent 10 years as a bench scientist at Monogram Bioscience (formerly Virologic), followed by 8 years at Bristol Myers Squibb and most recently 4 years at the early detection/liquid biopsy company, Freenome, where she led the scientific and medical affairs team.

Signe holds a Bachelor of Science from Simon Fraser University in British Columbia, Canada and a Master of Science in Medical Sciences, Molecular Immunology, and Virology from McMaster University in Ontario, Canada.